27.07.2013 Views

Elektronisk udgave - Sundhedsstyrelsen

Elektronisk udgave - Sundhedsstyrelsen

Elektronisk udgave - Sundhedsstyrelsen

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

xxii<br />

effectiveness identified. Insufficient results of cost evaluations notwithstanding,<br />

it can be assumed that TXA and aprotinin would be<br />

the most cost-effective of the technologies. However, knowledge of<br />

the short as well as in the long term side effects is insufficient. Use<br />

of aprotinin must be deemed acceptable even though aprotinin is<br />

more expensive than TXA, considering that aprotinin, more surely<br />

than TXA, can prevent re-operations caused by bleeding. From a<br />

Danish perspective antifibrinolytic drugs could be a very interesting<br />

field for some of the fields of specialisation.<br />

EPO<br />

Abroad, especially in the United States, the use of EPO is closely<br />

connected with a considerably more widespread use of PAD (which,<br />

as in the case of EPO, is not cost-effective) than in Denmark. In<br />

Denmark EPO is not deemed a technology suitable for use in more<br />

or less standard treatment to limit blood requirements. Only in very<br />

special cases (e.g. when a Jehovah’s Witness undergoes an operation<br />

or in the case of very specific groups of patients) the use of EPO can<br />

be deemed relevant.<br />

ANH<br />

The examination of the effectiveness of ANH is weakened by methodological<br />

problems, but in general ANH could be seen as an applicable<br />

and useful technology in Danish hospitals, e.g. in connection<br />

with major operations on younger people. However, the use of<br />

ANH requires some planning and coordination (between anesthesiological<br />

and surgical personnel and possibly the blood bank) and<br />

may thus be time-consuming. With increased evidence of its effectiveness<br />

it cannot be excluded that in the long term ANH might become<br />

a relevant area of development in Denmark.<br />

Autotransfusion/CS<br />

From a clinical point of view autotransfusion/CS appears to be the<br />

perhaps most interesting of the examined technologies; this is a<br />

technology which would also be directly applicable and useful<br />

within the Danish hospital service. However, one objection can be<br />

raised, namely that the potential risk of spreading bone, tissue and<br />

plastic particles has not been investigated sufficiently yet, neither in<br />

relation to intraoperative and postoperative use, nor in a long-term<br />

perspective. Using blood which has been washed would presumably<br />

help to reduce this problem. On the other hand, equipment for

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!